[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
About Journal::
Editorial Board::
Articles Archive::
Indexing Databases::
To Authors::
To Reviewers::
Submit Your Article::
Policies and Publication Ethics::
Archiving Policy::
Site Facilities::
Contact Us::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 6, Issue 3 (6-2019) ::
2019, 6(3): 4-11 Back to browse issues page
Up-regulation of circulating miR-93-5p in patients with relapsing-remitting multiple sclerosis
Jalil Shafiei , Gholamreza Javadi , Behnaz Nateghi , Vahid Shaygannejad , Mansoor Salehi
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran , M_salehi@med.mui.ac.ir
Abstract:   (2501 Views)
Introduction: Multiple sclerosis (MS) is an inflammatory demyelinating in which there is no standardized method to detect this disease activity. It has shown abnormal microRNAs (miRNAs) function in peripheral blood immune cells. miRNAs expression is probably responsible for immunological features associated with MS. The purpose of the current study was to investigate the association of miR-93-5p expression with MS disease.
Materials and methods: In this case-control study, a totally of 30 relapsing-remitting MS (RRMS) patients and 30 healthy subjects were enrolled. Following miRNA extraction and cDNA synthesis, miR-93-5p expression was examined in peripheral blood mononuclear cells (PBMCs) using real-time polymerase chain reaction.
Results: The expression of miR-93-5p was significantly increased in RRMS patients compared to healthy subjects (P=0.001). Receiver operating curve (ROC) analysis identified a strong predictive power of miR‑93-5p on discriminating MS from healthy individuals, with the area under the curve (AUC) of 0.939 (95% CI; 0.8581-1.000). On the other hand, the samples were analyzed based on the type of drug treatment (interferon and non-interferon), which did not show any considerable differences (P=0.863).
Conclusion: Our findings showed that miR-93-5p has highly elevated expression in patients with RRMS compared to healthy subjects. Based on the results miR-93-5p may be a prospective biomarker with the potential use for diagnosis of RRMS patients.
Keywords: Multiple sclerosis, MicroRNA, miR-93-5p
Full-Text [PDF 805 kb]   (859 Downloads)    
Type of Study: Research | Subject: Genetics
Received: 2019/09/12 | Accepted: 2019/11/24 | Published: 2019/12/20
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shafiei J, Javadi G, Nateghi B, Shaygannejad V, Salehi M. Up-regulation of circulating miR-93-5p in patients with relapsing-remitting multiple sclerosis. Journal of Basic Research in Medical Sciences 2019; 6 (3) :4-11
URL: http://jbrms.medilam.ac.ir/article-1-441-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 3 (6-2019) Back to browse issues page
مجله ی تحقیقات پایه در علوم پزشکی Journal of Basic Research in Medical Sciences
Persian site map - English site map - Created in 0.15 seconds with 41 queries by YEKTAWEB 4654